Intravesical Administration

Subscribe to Selected New Research on Intravesical Administration

905 relevant articles (90 outcomes, 134 trials/studies) found for this Therapy

Description: The instillation or other administration of drugs into the bladder, usually to treat local disease, including neoplasms.

Also Known As:

Administration, Intravesical; Administration, Intravesical Drug; Injections, Intravesical; Intravesical Injection; Intravesical Instillation; Administration, Bladder Drug; Administrations, Bladder Drug; Administrations, Intravesical; Administrations, Intravesical Drug; Bladder Drug Administrations; Bladder Instillation; Bladder Instillations; Drug Administration, Intravesical; Drug Administrations, Bladder; Drug Administrations, Intravesical; Injection, Intravesical; Instillation, Intravesical; Instillations, Bladder; Instillations, Intravesical; Intravesical Administrations; Intravesical Drug Administrations; Intravesical Injections; Intravesical Instillations; Bladder Drug Administration; Drug Administration, Bladder; Instillation, Bladder; Intravesical Drug Administration

Relationship Network

Therapy Context: Research Results

Therapeutics: 6127

Drug Therapy: 124082

Drug Administration Routes: 7

Topical Administration: 574

Intravesical Administration: 905

Related Diseases

1.	Urinary Bladder Neoplasms (Bladder Cancer) 10/01/2008 - "CONCLUSIONS: Intravesical instillation of BCG is the most effective in the long term when chosen as the initial prophylactic therapy for the prevention of recurrence in superficial bladder cancer." 07/01/2006 - "Intravesical instillation of Bacillus Calmette-Guérin (BCG) after transurethral resection is the most effective treatment for superficial bladder cancers. " 06/01/2003 - "CONCLUSIONS: The data suggest that intravesical instillation of BCG is more effective when no prior treatment has been attempted, and that best results may be achieved if BCG is chosen as the initial therapy for superficial bladder cancer. " 12/01/1990 - "Intravesical administration of bacillus Calmette-Guerin has been shown to be highly effective treatment of superficial bladder cancer. " 10/01/1986 - "Intravesical instillation of bacille Calmette Guerin (BCG) currently is considered the most effective treatment for recurrent superficial bladder cancer, but little is known about the mechanism of action. " Order ALL the reference details at left...
2.	Neoplasms (Cancer) 05/01/1997 - "Our multi-institutional studies revealed that the direct efficacy of BCG, intravesical instillation for treatment of an existing tumor is very promising. " 01/01/1987 - "The following conclusions are derived: 1) If bladder instillation therapy aims only at complete remission (CR), tumors over 1 cm in diameter should be excluded, because this is the theoretical size limit beyond which instillation therapy cannot lead to CR. " 01/01/1993 - "In numerous studies, involving over 3,000 patients, intravesical instillation of BCG has been shown to be an effective treatment for superficial cancer of the urinary bladder in humans. " 11/01/2008 - "CONCLUSION: Early use of single intravesical instillation of HYD plus subsequent regular intravesical instillation of BCG is markedly effective for preventing postoperative recurrence of bladder transitional cell cancer, with few adverse events." 01/01/1989 - "Intravesical instillations of BCG are effective in preventing tumor recurrence, eliminating existing tumor and treating CIS in a substantial number of patients. " Order ALL the reference details at left...
3.	Carcinoma (Carcinomatosis) 03/01/1994 - "Immunotherapy with intravesical instillation of bacillus Calmette-Guérin (BCG) is an effective treatment for superficial bladder carcinoma. " 03/01/1993 - "Intravesical administration of bacillus Calmette-Guerin (BCG) is an effective treatment for superficial carcinoma of the bladder. " 02/01/1993 - "Intravesical administration of Calmette-Guérin bacillus (BCG) is effective in the treatment of superficial bladder carcinoma. " 06/01/1996 - "PURPOSE: Superficial bladder carcinoma, treated by resection and intravesical administration of bacillus Calmette-Guérin (BCG), yields a remission rate that approaches 70%. " 01/01/1999 - "However, many studies suggest that immunological response is related to effectiveness of intravesical instillation of BCG in the therapy for superficial bladder carcinoma. " Order ALL the reference details at left...
4.	Cystitis 11/01/2001 - "Two patients have presented a begnin and transient inflammatory cystitis after reiterated instillation.DISCUSSION-CONCLUSION: Intravesical instillation of capsaïcin are an effective treatment for incontinence and associated symptoms caused by neurogenic detrusor hyperactivity. " 02/01/2008 - "MATERIALS AND METHODS: Bacterial cystitis was induced by intravesical instillation of Escherichia coli 1677 in female C57BL/6N and C3H/OuJ mice (Jackson Laboratories, Bar Harbor, Maine). " 10/01/2007 - "MATERIALS AND METHODS: Chronic cystitis was induced by intravesical instillation of 0.2 mL of 0.4 m HCl in female adult rats. " 09/01/2007 - "Eosinophilic cystitis induced by bacillus Calmette-Guerin (BCG) intravesical instillation." 01/01/2001 - "MATERIAL AND METHODS: We have studied the treatment of severe BCG cystitis with a anaesthetic anti-inflammatory solution administered by intravesical instillations to 16 patients. " Order ALL the reference details at left...
5.	Transitional Cell Carcinoma 01/15/2003 - "Intravesical instillation of bacille Calmette-Guérin (BCG) effectively treats transitional cell carcinoma of the bladder. " 02/01/1993 - "Intravesical instillation of Bacillus Calmette-Guérin (BCG) offers safe and effective short-term/long-term treatment for superficial transitional cell carcinoma (TCC) and TCC in situ of the bladder. " 07/01/1986 - "[Prophylactic chemotherapy of transitional cell carcinoma of the bladder: the efficacy of long-term bladder instillation]" 11/01/2002 - "METHODS: Thirty-seven consecutive patients with initial T1G3 transitional cell carcinoma, who had undergone complete transurethral resection, followed by 6 weeks of intravesical instillation of bacille Calmette-Guérin (BCG), and with at least 1 year of follow-up, were enrolled in the study. " 09/01/2009 - "A 62-year-old man with transitional-cell carcinoma of the bladder had undergone transurethral resection and adjuvant treatment with several intravesical instillations of bacillus Calmette-Guerin 10 months earlier. " Order ALL the reference details at left...

Related Drugs and Biologics

1.	Doxorubicin (Adriamycin)
2.	Epirubicin (Ellence)
3.	Thiotepa (Triethylenethiophosphoramide)
4.	gemcitabine
5.	oxybutynin (Tavor)
6.	Bleomycin (Blenoxane)
7.	Dimethyl Sulfoxide (DMSO)
8.	ADM protocol
9.	Carbazilquinone (Carboquone)
10.	Alprostadil (Muse)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)
2.	Immunotherapy
3.	Oral Administration
4.	Indwelling Catheters (Arterial Line)
5.	Induced Hyperthermia (Thermotherapy)

Best Treatments:
Research Summary Report
on Urinary Bladder Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 641 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>